Site Editor

William J. Gradishar, MD, FACP, FASCO

Advertisement
Advertisement

Seema Khan, MD, on ECOG-ACRIN 4112: Which Patients May Be Spared Radiotherapy for Ductal Carcinoma in Situ?

Posted: Tuesday, June 4, 2024

Seema Khan, MD, of Northwestern University and the Robert H. Lurie Comprehensive Cancer Center, discusses study results supporting the omission of radiotherapy after surgery in patients with ductal carcinoma in situ who have low DCIS scores and its use in patients who have intermediate/high DCIS scores. She explores the impact these results might have on clinical decision-making in these populations.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.